Efficacy of infliximab for disc herniation-induced sciatica: One-year follow-up

Spine

Volumn 29, Issue 19, 2004, Pages 2115-2119

  Korhonen, Timo ^a   Karppinen, Jaro ^a,b,c   Malmivaara, Antti ^b,c,d   Autio, Reijo ^a   Niinimäki, Jaakko ^a   Paimela, Leena ^c   Kyllönen, Eero ^a   Lindgren, Karl August ^c   Tervonen, Osmo ^a   Seitsalo, Seppo ^c   Hurri, Heikki ^c  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^c ORTON ORTHOPAEDIC HOSPITAL   (Finland)

^d Finnish Off Hlth Care Technol A   (Finland)

Author keywords

Clinical trial; Infliximab; Intervertebral disc herniation; Sciatica; TNF ; Treatment

Indexed keywords

INFLIXIMAB; METHYLPREDNISOLONE; SODIUM CHLORIDE; STEROID; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DISABILITY; DISEASE SEVERITY; DRUG EFFICACY; DRUG INFUSION; FOLLOW UP; HUMAN; INTERVERTEBRAL DISK HERNIA; ISCHIALGIA; LEG PAIN; LOW BACK PAIN; LUMBAR SPINE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPEN STUDY; OSWESTRY LOW BACK DISABILITY QUESTIONNAIRE; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; SENSORIMOTOR FUNCTION; SIDE EFFECT; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

EID: 20144376736     PISSN: 03622436     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.brs.0000141179.58778.6c     Document Type: Article

References (23)

1. Igarashi T, Kikuchi S, Shubayev V, et al. Volvo Award winner in basic science studies: exogenous tumor necrosis factor-alpha mimics nucleus pulposus-induced neuropathology. Molecular, histologic, and behavioral comparisons in rats. Spine 2000;25:2975-80.
2. Aoki Y, Rydevik B, Kikuchi S, et al. Local application of disc-related cytokines on spinal nerve roots. Spine 2002;27:1614-7.
3. Olmarker K, Rydevik B. Selective inhibition of tumor necrosis factor-alpha prevents nucleus puiposus-induced thrombus formation, intraneural edema, and reduction of nerve conduction velocity: possible implications for future pharmacologic treatment strategies of sciatica. Spine 2001;26:863-9.
4. Karppinen J, Korhonen T, Malmivaara A et al. Tumor necrosis factor-α monoclonal antibody, infliximab, used to manage severe sciatica. Spine 2003;28:750-3.
5. Haro H, Crawford HC, Fingleton B, et al. Matrix metalloproteinase-7- dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption. J Clin Invest 2000;105:143-50.
6. Centocor B.V. Current Summary of Product Characteristics for Chimeric Monoclonal Antibody Against TNF-á, Infliximab, Remicade. Leiden, The Netherlands: Centocor B.V., 2002.
7. Fairbank JC, Couper J, Davies JB, et al. The Oswestry low back pain disability questionnaire. Physiotherapy 1980;66:271-3.
8. Karppinen J, Maimivaara A, Kurunlahti M et al. Periradicular infiltration for sciatica: a randomized controlled trial. Spine 2001;26:1059-67.
9. Autio RA, Karppinen J, Kuruniahti M, et al. Effect of periradicular methyl-prednisolone on spontaneous resorption of disc herniations. Spine 2003;29: 1601-70.
10. Keskimäki I, Seitsalo S, Österman H, et al. Reoperations after lumbar disc surgery: a population-based study of regional and interspecialty variations. Spine 2000;25:1500-8.
11. Ikeda T, Nakamura T, Kikuchi T, et al. Pathomechanism of spontaneous regression of the herniated lumbar disc: histologic and immunohistochemical study. J Spinal Disord 1996;9:136-40.
12. Doita M, Kanatani T, Ozaki T, et al. Influence of macrophage infiltration of herniated disc tissue on the production of matrix metalloproteinases leading to disc resorption. Spine 2001;26:1522-7.
13. Haro H, Kato T, Komori H, et al. Vascular endothelial growth factor (VEGF)-induced angiogenesis in herniated disc resorption. J Orthop Res 2002;20:409-15.
14. Paleolog EM, Young S, Stark AC, et al. Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis. Arthritis Rheum 1998;41:1258-65.
15. Minamide A, Tamaki T, Hashizume H, et al. Effects of steroid and lipopolysaccharide on spontaneous resorption of herniated intervertebral discs: an experimental study in the rabbit. Spine 1998;23:870-6.
16. Tobinick EL, Britschgi-Davoodifar S. Perispinal TNF-alpha inhibition for discogenic pain. Swiss Med Wkly 2003;133:170-7.
17. Shubayev VI, Myers RR. Upregulation and interaction of TNFalpha and gelatinases A and B in painful peripheral nerve injury. Brain Res 2000;855: 83-9.
18. Shubayev VI, Myers RR. Axonal transport of TNF-alpha in painful neuropathy: distribution of ligand tracer and TNF receptors. J Neuroimmunol 2001;114:48-56.
19. Shubayev VI, Myers RR. Anterograde TNF alpha transport from rat dorsal root ganglion to spinal cord and injured sciatic nerve. Neurosci Lett 2002; 320:99-101.
20. Kawakami M, Tamaki T, Matsumoto T, et al. Role of leukocytes in radicular pain secondary to herniated nucleus pulposus. Clin Orthop 2000;376:268-77.
21. Maini RN, Feldmann M. How does infliximab work in rheumatoid arthritis? Arthritis Res 2002;4(suppl 2):22-8.
22. ten Hove T, van Montfrans C, Peppelenbosch MP, et al. Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease. Gut 2002;50:206-11.
23. Sturm A, Fiocchi C. Life and death in the gut: more killing, less Crohn's. Gut 2002;50:148-9.